Phase IV, Non Randomized Study in ARV Experienced Patients Under Switch Therapy With Kaletra

Trial Profile

Phase IV, Non Randomized Study in ARV Experienced Patients Under Switch Therapy With Kaletra

Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Mar 2013

At a glance

  • Drugs Lopinavir/ritonavir (Primary) ; Nucleoside reverse transcriptase inhibitors
  • Indications HIV infections
  • Focus Therapeutic Use
  • Acronyms NEXT
  • Sponsors Abbott Laboratories
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 14 Mar 2013 Status changed from discontinued to completed as reported by ClinicalTrials.gov.
    • 23 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top